Kendra Huseman
Oklahoma Medical Research Foundation
3 Papers
Kendra Huseman is an academic researcher from Oklahoma Medical Research Foundation. The author has contributed to research in topics: Internal medicine & Chemistry. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Protein imbalance in the development of skeletal muscle wasting in tumour‐bearing mice
Jacob L. Brown,David E. Lee,Megan E. Rosa-Caldwell,Lemuel A. Brown,Lemuel A. Brown,Richard A. Perry,Wesley S. Haynie,Kendra Huseman,Kavithalakshmi Sataranatarajan,Holly Van Remmen,Holly Van Remmen,Tyrone A. Washington,Michael P. Wiggs,Nicholas P. Greene +13 more
TL;DR: Skeletal muscle protein turnover throughout the development of cancer cachexia in tumour‐bearing mice is examined to examine the mechanisms controlling development of tumour-induced muscle wasting and the progression and development ofcancer cachexia are underexplored.
99
Nrf2 deficiency exacerbates age-related contractile dysfunction and loss of skeletal muscle mass
Bumsoo Ahn,Gavin Pharaoh,Gavin Pharaoh,Pavithra Premkumar,Kendra Huseman,Rojina Ranjit,Michael Kinter,Michael Kinter,Luke I. Szweda,Tamas Kiss,Gabor A. Fulop,Stefano Tarantini,Anna Csiszar,Zoltan Ungvari,Holly Van Remmen,Holly Van Remmen,Holly Van Remmen +16 more
TL;DR: Graphical abstract fx1 as discussed by the authors is an extension of the fx2-graphical abstract of the Fx1 graph, which is used in this paper, and is used here.
80
Restoration of SERCA ATPase prevents oxidative stress-related muscle atrophy and weakness.
Rizwan Qaisar,Shylesh Bhaskaran,Rojina Ranjit,Kavithalakshmi Sataranatarajan,Pavithra Premkumar,Kendra Huseman,Holly Van Remmen,Holly Van Remmen +7 more
TL;DR: In this paper, the activation of Sarcoplasmic Reticulum (SR) Ca2+ ATPase (SERCA) with CDN1163, a novel small molecule allosteric SERCA activator, ameliorates the muscle impairment in the CuZnSOD deficient (Sod1-/-) mouse model of oxidative stress.
78